NCT00766545View on ClinicalTrials.gov

Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.

PHASE3CompletedINTERVENTIONAL
Enrollment

1,095

Participants

Timeline

Start Date

April 30, 1992

Primary Completion Date

March 31, 1997

Study Completion Date

March 31, 1997

Conditions
Cerebral Infarction
Interventions
DRUG

cilostazol

oral tablet 100 mg, twice daily, over 1 year

DRUG

placebo of cilostazol

oral tablet, 0 mg twice daily, over 1 year

Trial Locations (1)

Unknown

Kanto Area

Sponsors
All Listed Sponsors
lead

Otsuka Pharmaceutical Co., Ltd.

INDUSTRY